Using whole-body MRI to identify significant health issues in the general population
Official title: A Multi-Site Prospective, Single-Arm, Observational Study On The Accuracy Of Whole Body Magnetic Resonance Imaging (Wb-Mri) Screening To Predict Clinically Significant Diagnoses In General Population Subjects Interested In Proactive And Advanced General Preventive Healthcare.
Run by Hercules · NCT06212479 · Data updated 2026-11-12
This study is testing if whole-body MRI scans can help find serious health problems like cancer and heart issues in people aged 18 and older.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100000 (estimated) |
| Sponsor | Hercules Industry-sponsored |
| Locations | 1 site (Watertown, Massachusetts) |
| Status | Recruiting |
| Started | May 17, 2024 |
| Main results expected | January 2034 |
| Study ends | January 2037 |
| Registry record updated | April 30, 2025 |
| Trial ID | NCT06212479 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older who are interested in proactive healthcare and meet the study's inclusion criteria.
✕Probably not a fit
Patients with contraindicated medical devices or those who are pregnant may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to evaluate the accuracy of whole-body magnetic resonance imaging (WB-MRI) in predicting clinically significant diagnoses among a diverse group of participants aged 18 and older. Up to 100,000 subjects will be recruited from multiple clinical sites across the United States, with careful adherence to inclusion and exclusion criteria. Participants will undergo WB-MRI scans, and data will be collected to assess the effectiveness of this screening method in identifying conditions such as cancer, metabolic diseases, aneurysms, and neurologic disorders.
Why it matters
Potential benefit: If successful, this study could enhance early detection of serious health conditions, leading to improved patient outcomes.
How similar studies have gone: While the use of WB-MRI for screening is gaining interest, this specific approach is relatively novel and has not been extensively tested in large populations.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Each subject MUST: * Be\>=18 years of age at the time of enrollment. * Be able to read and understand provided procedural information for the study; * Be able and willing to follow all study procedures including proper breathing and body movement minimization while within the WB-MRI system; * Be willing and able to provide required clinical, demographic, medical history, and concomitant medications information; * Be able to provide financial payment in advance for reimbursement of the cost of the WBMRI acquisition procedure and interpretation; * Complete all required consent procedures. Exclusion Criteria: * Harbor within their bodies contraindicated medical devices including, but not limited to, implanted pacemakers, intracranial aneurysm clips, cochlear implants, drug infusion pumps, neurostimulators, bone growth stimulators, certain intrauterine contraceptive devices, non- MRI safe metals, etc.; * Self-certify that they are pregnant; * Be seeking to undergo WB-MRI as a subject in this study in lieu of other covered dedicated diagnostic imaging evaluations when such covered procedures represent more appropriate or standard-of-care procedures by context-specific clinical indication; * Be an employee of the study site or the sponsor; * Have a medical condition or serious intercurrent illness, or other circumstance that, in the Investigator's judgment, could jeopardize the candidate's safety as a study subject, or that could interfere with study objectives.
Where it's running
-
Hercules Research Center
Watertown, Massachusetts, United States Recruiting
Study contacts
- Principal investigator: Perry Kaneriya, MD, MBA — Hercules
- Study coordinator: Kayla MacLeod, BS
- Email: kayla.macleod@herculesstudy.org
- Phone: (301) 450-4451
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Long-term observation of ultra-rare inherited neurological diseases.
This study is looking to learn more about very rare inherited neurological diseases by tracking and collecting information from patients over a long time to see how these conditions change and affect their lives.
-
Individual patient data analysis of Gore Iliac Branched Endoprosthesis patients
This project tests how well the Gore Iliac Branched Endoprosthesis works by pooling detailed patient data from published studies to see patterns in outcomes.
-
CTX310 for refractory high triglycerides or LDL cholesterol
This trial will test whether a single IV dose of CTX310 is safe and tolerated in adults whose high triglycerides or LDL cholesterol have not responded to available treatments.
-
Safety and tolerability of SNS851 in healthy adults.
This study will test whether a new injectable drug called SNS851 is safe and well-tolerated when given under the skin to healthy adults aged 18 to 55.
-
Ask Questions About Clinical Trials: A Tool to Help Patients Discuss Trials
This study tests a patient-friendly brochure called the ASQ-CT to see if it helps adults with cancer, heart disease, or neurologic conditions talk with their providers about clinical trials.
-
Postoperative breathing problems after (adeno)tonsillectomy in children with sleep apnea
See how common breathing problems are after (adeno)tonsillectomy in children with obstructive sleep apnea and which factors raise the risk.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.